Cargando…

A trial of mithramycin in the treatment of advanced malignant disease.

Detalles Bibliográficos
Autores principales:	Sewell, I. A., Ellis, H.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1966
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008976/ https://www.ncbi.nlm.nih.gov/pubmed/5329342

Ejemplares similares

A clinical trial of mithramycin in the treatment of advanced malignant disease.
por: Baum, M.
Publicado: (1968)

A trial of streptonigrin in the treatment of advanced malignant disease.
por: Smith, G. M., et al.
Publicado: (1967)

Nanoparticulate formulations of mithramycin analogs for enhanced cytotoxicity
por: Scott, Daniel, et al.
Publicado: (2011)

Nano-Encapsulation of Mithramycin in Transfersomes and Polymeric Micelles for the Treatment of Sarcomas
por: Estupiñán, Óscar, et al.
Publicado: (2021)

Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor
por: Chasse, Maggie H, et al.
Publicado: (2020)

Mithramycin delivery systems to develop effective therapies in sarcomas
por: Estupiñán, Óscar, et al.
Publicado: (2021)

Mithramycin Treatment of Hypercalcaemia and Renal Failure in a Patient with Paratesticular Embryonic Sarcoma
por: Parsons, V., et al.
Publicado: (1971)

Mithramycin interacts with core histones and modulates epigenetic modifications
por: Banerjee, Amrita, et al.
Publicado: (2013)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)

Mithramycin selectively attenuates DNA-damage-induced neuronal cell death
por: Makarevich, Oleg, et al.
Publicado: (2020)

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
por: Federico, Aniello, et al.
Publicado: (2020)

Letter: Renal function and electrolyte disturbances in normocalcaemic and hypercalcaemic patients treated with mithramycin.
por: Fillastre, J. P., et al.
Publicado: (1974)

Mithramycin Targets Sp1 and The Androgen Receptor Transcription Level—Potential Therapeutic Role in Advanced Prostate Cancer
por: Wang, Long G., et al.
Publicado: (2006)

Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells
por: Quarni, Waise, et al.
Publicado: (2019)

Heterologous reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, the aglycon of antitumor polyketide mithramycin
por: Zabala, Daniel, et al.
Publicado: (2020)

Modulation of the Activity of Sp Transcription Factors by Mithramycin Analogues as a New Strategy for Treatment of Metastatic Prostate Cancer
por: Malek, Anastasia, et al.
Publicado: (2012)

Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes
por: Liacini, Abdelhamid, et al.
Publicado: (2005)

Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021)

Genome-Wide Modulation of Gene Transcription in Ovarian Carcinoma Cells by a New Mithramycin Analogue
por: Vizcaíno, Carolina, et al.
Publicado: (2014)

Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia
por: Capretto, Lorenzo, et al.
Publicado: (2012)

Mithramycin A Alleviates Osteoarthritic Cartilage Destruction by Inhibiting HIF-2α Expression
por: Choi, Moon-Chang, et al.
Publicado: (2018)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences
por: Barceló, Francisca, et al.
Publicado: (2007)

Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer
por: Choi, Eun-Sun, et al.
Publicado: (2014)

Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1
por: Hou, Caixia, et al.
Publicado: (2016)

Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection
por: Stagnoli, Soledad, et al.
Publicado: (2023)

Anticancer drug mithramycin interacts with core histones: An additional mode of action of the DNA groove binder
por: Banerjee, Amrita, et al.
Publicado: (2014)

The chromomycin CmmA acetyltransferase: a membrane‐bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin
por: García, Beatriz, et al.
Publicado: (2011)

Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
por: Tornin, Juan, et al.
Publicado: (2016)

Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma
por: Liu, Xu-Jie, et al.
Publicado: (2017)

Mithramycin forms a stable dimeric complex by chelating with Fe(II): DNA-interacting characteristics, cellular permeation and cytotoxicity
por: Hou, Ming-Hon, et al.
Publicado: (2005)

Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors
por: Otjacques, Eléonore, et al.
Publicado: (2013)

Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration
por: Sleiman, Sama F., et al.
Publicado: (2011)

PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells
por: Bavelloni, Alberto, et al.
Publicado: (2014)

Increase of microRNA-210, Decrease of Raptor Gene Expression and Alteration of Mammalian Target of Rapamycin Regulated Proteins following Mithramycin Treatment of Human Erythroid Cells
por: Bianchi, Nicoletta, et al.
Publicado: (2015)

The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C
por: Linke, Charlotte, et al.
Publicado: (2023)

Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin
por: Beaulieu, E, et al.
Publicado: (2011)

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042)
por: Fernández-Guizán, Azahara, et al.
Publicado: (2015)

Mithramycin A induces apoptosis by regulating the mTOR/Mcl-1/tBid pathway in androgen-independent prostate cancer cells
por: Choi, Eun-Sun, et al.
Publicado: (2013)

Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences
por: Finotti, Alessia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h7cchk2mn4nn3hhajslqm86ks4